The Strength of Association Between Surrogate End Points and Survival in Oncology

This is the authors' abstract. We don't add key points for this paper.

Most trial-level validation studies of surrogate end points in oncology find low correlations with survival. All validation studies use only a subset of available trials. The evidence supporting the use of surrogate end points in oncology is limited.